Alan Huang
2022
In 2022, Alan Huang earned a total compensation of $1.8M as Chief Scientific Officer at Tango Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,550 |
|---|---|
| Option Awards | $1,197,000 |
| Salary | $425,385 |
| Other | $2,966 |
| Total | $1,818,901 |
Huang received $1.2M in option awards, accounting for 66% of the total pay in 2022.
Huang also received $193.6K in non-equity incentive plan, $425.4K in salary and $3K in other compensation.
Rankings
In 2022, Alan Huang's compensation ranked 1,911th out of 5,760 executives tracked by ExecPay. In other words, Huang earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,911 out of 5,760 | 67th |
Division Manufacturing | 1,014 out of 3,136 | 68th |
Major group Chemicals And Allied Products | 427 out of 1,422 | 70th |
Industry group Drugs | 392 out of 1,323 | 70th |
Industry Pharmaceutical Preparations | 282 out of 969 | 71st |
Source: SEC filing on April 24, 2023.
Huang's colleagues
We found two more compensation records of executives who worked with Alan Huang at Tango Therapeutics in 2022.